NIH’s NIAID initiating dose evaluation studies in animal models of Pluristem’s PLX-R18 in the treatment of acute radiation syndrome

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, has announced that the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Aid / Disasters News From Medical News Today BEST DEAL UPDATE: SPECIAL … Read more…

State Highlights: DOJ Outlines Efforts To Address Rural Safety Crisis In Alaska; Activists File Lawsuit Over New Hampshire’s Treatment Of Mental Health Patients In ERs

Media outlets report on news fro Alaska, New Hampshire, California, North Carolina, Massachusetts, Virginia, Minnesota, Florida, Connecticut, Wisconsin, Georgia, Ohio, Missouri, and Maryland. Kaiser Health News BEST DEAL UPDATE:

Commentary: Novartis CEO: Gene therapy offers hope of cures in a treatment, but US needs new pricing, payment model

The current global health system treats chronic diseases with a pay-as-you-go model, spreading costs over months and years. It's unprepared to pay for a surge of new, single-treatment therapies with the potential to provide a lifetime of benefit. Health and … Read more…

New treatment could become first targeted therapy designed for ‘untreatable’ childhood brain cancer

A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease. The prototype treatment could also offer hope for patients with the rare and … Read more…

Coachella Security Guards Allege Inhumane Treatment: ‘People Over Here Are Starving’

Matt Winkelmeyer/Getty Every year, music lovers and miscellaneous basics flood Indio, California, for the Coachella Valley Music and Arts Festival. Coachella is known for its huge headlining artists and general aura of douchebaggery—the stereotypical festivalgoer is a rich kid sporting … Read more…

Childhood methylphenidate treatment predicts antidepressant use during adolescence

A new, 12-year longitudinal study, which monitored 6,830 children from early childhood into adolescence, has shown that consistent treatment with MPH-based medications during childhood increases the risk of antidepressant use during adolescence. The study is the first of its kind … Read more…

Alzheimer’s treatment holds promise for primary progressive aphasia patients

Scientists have discovered that an existing therapy frequently used to treat Alzheimer’s disease might also work on patients with primary progressive aphasia (PPA), a type of dementia that destroys language and currently has no treatment. Child Development News — ScienceDaily … Read more…

Immersive virtual reality therapy shows lasting effect in treatment of phobias in children with autism

New research shows that an immersive virtual reality environment treats 45 percent of children with autism, freeing them from their fears and phobias — and that the treatment lasts. Child Development News — ScienceDaily SPECIAL DISCOUNT DEAL UPDATE: